Contract Research And Manufacturing Service (CRAMS) Market In India 2024-2028
The contract research and manufacturing service (CRAMS) market in India is forecasted to grow by USD 14.08 bn during 2023-2028, accelerating at a CAGR of 10.8% during the forecast period. The report on the contract research and manufacturing service (CRAMS) market in India provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by diverse range of service offerings by CRAMS providers, availability of cost-effective solutions for research, development, and manufacturing services, and presence of highly skilled workforce in pharmaceutical sciences and biotechnology.
Technavio's contract research and manufacturing service (CRAMS) market in India is segmented as below:
By Service
By Therapeutic Area
- Cardiovascular
- Infectious disease
- Endocrine disease
- Oncology
- Gastrointestinal and others
By End-user
- Pharmaceutical and biopharmaceutical companies
- Medical device companies
- Academic and research institutes
By Geographical Landscape
This study identifies the technological advancements in CRAMS as one of the prime reasons driving the contract research and manufacturing service (CRAMS) market in India growth during the next few years. Also, increasing number of US FDA-approved manufacturing facilities and increasing outsourcing of research and manufacturing activities by AMEs will lead to sizable demand in the market.
The report on the contract research and manufacturing service (CRAMS) market in India covers the following areas:
- Contract research and manufacturing service (CRAMS) market in India sizing
- Contract research and manufacturing service (CRAMS) market in India forecast
- Contract research and manufacturing service (CRAMS) market in India industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading contract research and manufacturing service (CRAMS) market in India vendors that include Aragen Life Sciences Pvt. Ltd., Arch Pharmalabs Ltd., Aurobindo Pharma Ltd., BHAGWATI ORGANICS PVT. LTD., Biocon Ltd., Dhanuka Agritech Ltd., Dishman Carbogen Amcis Ltd., Divis Laboratories Ltd., Ind Swift Laboratories Ltd., Ipca Laboratories Ltd., Jubilant Pharmova Ltd., Lupin Ltd., Merck and Co. Inc., MSN Laboratories, Murli Krishna Pharma, Piramal Enterprises Ltd., Solara, Sun Pharmaceutical Industries Ltd., TCG Lifesciences Pvt. Ltd., and Wockhardt Ltd.. Also, the contract research and manufacturing service (CRAMS) market in India analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.